# Acthar on Proteinuria in IgA Nephropathy Patients

> **NCT02382523** · PHASE4 · WITHDRAWN · sponsor: **Baylor College of Medicine**

## Conditions studied

- IgA Nephropathy
- Proteinuria

## Interventions

- **DRUG:** Acthar 80 unit injection

## Key facts

- **NCT ID:** NCT02382523
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-02
- **Primary completion:** 2019-01
- **Final completion:** 2020-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** There were no subjects enrolled locally on this study since it opened. Local IRB closure has been requested.
- **Last updated:** 2017-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02382523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02382523, "Acthar on Proteinuria in IgA Nephropathy Patients". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02382523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*